Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included Medicare cuts hospital payments over readmissions; a second-generation chimeric antigen receptor T-cell therapy shows promise; a diabetes drug is approved to prevent kidney failure for the first time.
Read more about the stories in this podcast:
What We're Reading: Medicare Issues Readmission Penalties; Virginia Abortion Law Ruling; Vitamin A's Role in Skin Cancer: https://www.ajmc.com/newsroom/what-were-reading-medicare-issues-readmission-penalties-virginia-abortion-law-ruling-vitamin-as-role-in-skin-cancer-
PwC Report Urges Action to Tackle Social Determinants of Health: https://www.ajmc.com/focus-of-the-week/pwc-report-urges-action-to-tackle-social-determinants-of-health
Researchers Say Second-Generation CAR T-Cell Therapy Proves Successful in Early Studies, Human Trial Planned: https://www.ajmc.com/newsroom/researchers-say-secondgeneration-car-proves-successful-in-early-lab-studies-human-trial-planned
FDA Approves Canagliflozin to Prevent Kidney Failure, Hospitalization for Heart Failure: https://www.ajmc.com/focus-of-the-week/fda-approves-canagliflozin-to-prevent-kidney-failure-hospitalization-for-heart-failure
What We're Reading: DEA Authorized Opioid Production Surge; Georgia Abortion Law Blocked; Drone Deliveries for Healthcare: https://www.ajmc.com/newsroom/what-were-reading-dea-authorized-opioid-production-surge-georgia-abortion-law-blocked-drone-deliveries-for-healthcare
Patient-Centered Oncology Care—Innovation and Quality: New Directions in Value-Based Care: https://www.ajmc.com/pcoc-philadelphia-2019-11-08